BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• BioMidwest

  ASCO15: GenomeDx Biosciences’s Decipher Prostate Cancer Test Is Significant Predictor Of Metastasis In Patients With Detectable PSA Following Treatment With Radiation After Prostate Surgery, According To Study Presented At ASCO 2015 Annual Meeting

  June 1, 2015

   · 

  5 min read
• BioMidwest

  St. Jude Children’s Research Hospital Release: Study Finds Changes In Treatment Have Increased Life Span For Childhood Cancer Survivors

  June 1, 2015

   · 

  5 min read
• Business

  AMRI And HarkerBIO Ink Collaborative Agreement In Buffalo, N.Y.

  June 1, 2015

   · 

  4 min read
• Deals

  Actavis Completes Acquisition Of Auden Mckenzie

  June 1, 2015

   · 

  3 min read
• Drug Development

  Mirati Therapeutics Release: Initial Data From Ongoing Expansion Study Of MGCD265 Show Preliminary Evidence Of Clinical Efficacy In Heavily Pretreated Non-Small Cell Lung Cancer (NSCLC) Patients With MET Gene Alterations

  June 1, 2015

   · 

  15 min read
• Pharm Country

  NYU Langone Medical Center Release: Contact Lens Wearers Take Note: Your Eyes May Get More Infections Because Their “Microbiomes” Have Changed

  June 1, 2015

   · 

  4 min read
• Drug Development

  PharmaEngine, Inc. Announces Filing New Drug Application (NDA) Of MM-398 (PEP02) To Taiwan FDA As A Treatment For Post-Gemcitabine Metastatic Pancreatic Cancer

  June 1, 2015

   · 

  3 min read
• Drug Development

  Pharmamar Completes Patient Recruitment Of Phase III Registration Trial (ADMYRE) With APLIDIN(Plitidepsin) In Multiple Myeloma

  June 1, 2015

   · 

  2 min read
• Lone Star Bio

  Caris Life Sciences Presents New Tumor Profiling Research Providing Insights Into The Clinical Benefit Of Targeted Therapies For Colorectal Cancer Treatment-Resistant Subgroups

  June 1, 2015

   · 

  5 min read
• Business

  Rumor Has It: San Francisco’s Foresite Capital Closing Out $450 Million Life Science Fund

  June 1, 2015

   · 

  1 min read